Emerging insight of whole genome sequencing coupled with protein structure prediction into the pyrazinamide-resistance signature of Mycobacterium tuberculosis.
Int J Antimicrob Agents
; 63(4): 107053, 2024 Apr.
Article
in En
| MEDLINE
| ID: mdl-38081550
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyrazinamide
/
Mycobacterium tuberculosis
Limits:
Humans
Language:
En
Journal:
Int J Antimicrob Agents
Year:
2024
Document type:
Article
Affiliation country:
Taiwan
Country of publication:
Netherlands